DD232695A5 - Neue-1-phenylimidazolidin-2-on-derivate, ihre herstellung und verwendung - Google Patents

Neue-1-phenylimidazolidin-2-on-derivate, ihre herstellung und verwendung Download PDF

Info

Publication number
DD232695A5
DD232695A5 DD84265317A DD26531784A DD232695A5 DD 232695 A5 DD232695 A5 DD 232695A5 DD 84265317 A DD84265317 A DD 84265317A DD 26531784 A DD26531784 A DD 26531784A DD 232695 A5 DD232695 A5 DD 232695A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
compounds
group
alkyl
compound
Prior art date
Application number
DD84265317A
Other languages
German (de)
English (en)
Inventor
Anton Mentrup
Kurt Schromm
Ernst-Otto Renth
Gojko Muacevic
Armin Fuegner
Original Assignee
�������@������������@��k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������@������������@��k�� filed Critical �������@������������@��k��
Publication of DD232695A5 publication Critical patent/DD232695A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD84265317A 1983-07-18 1984-07-16 Neue-1-phenylimidazolidin-2-on-derivate, ihre herstellung und verwendung DD232695A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833325875 DE3325875A1 (de) 1983-07-18 1983-07-18 Neue 1-phenylimidazolidin-2-on-derivate, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
DD232695A5 true DD232695A5 (de) 1986-02-05

Family

ID=6204266

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84265317A DD232695A5 (de) 1983-07-18 1984-07-16 Neue-1-phenylimidazolidin-2-on-derivate, ihre herstellung und verwendung

Country Status (20)

Country Link
US (1) US4558061A (en, 2012)
EP (1) EP0131943A3 (en, 2012)
JP (1) JPS6038365A (en, 2012)
KR (1) KR850004746A (en, 2012)
AU (1) AU3079984A (en, 2012)
CS (1) CS244445B2 (en, 2012)
DD (1) DD232695A5 (en, 2012)
DE (1) DE3325875A1 (en, 2012)
DK (1) DK350284A (en, 2012)
ES (3) ES534380A0 (en, 2012)
FI (1) FI842853L (en, 2012)
GB (1) GB2146019B (en, 2012)
GR (1) GR82097B (en, 2012)
HU (1) HUT34957A (en, 2012)
IL (1) IL72421A0 (en, 2012)
NO (1) NO842922L (en, 2012)
PL (1) PL248780A1 (en, 2012)
PT (1) PT78934B (en, 2012)
SU (1) SU1287746A3 (en, 2012)
ZA (1) ZA845491B (en, 2012)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19822678A1 (de) * 1998-05-20 1999-11-25 Bayer Ag Substituierte 1,3-Diaza-2-(thi)oxo-cycloalkane

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen

Also Published As

Publication number Publication date
DK350284D0 (da) 1984-07-17
FI842853A7 (fi) 1985-01-19
GB2146019A (en) 1985-04-11
ZA845491B (en) 1986-03-26
KR850004746A (ko) 1985-07-27
GB8418266D0 (en) 1984-08-22
ES8603428A1 (es) 1985-12-16
IL72421A0 (en) 1984-11-30
GR82097B (en, 2012) 1984-12-13
DE3325875A1 (de) 1985-01-31
AU3079984A (en) 1985-01-24
SU1287746A3 (ru) 1987-01-30
FI842853L (fi) 1985-01-19
HUT34957A (en) 1985-05-28
PL248780A1 (en) 1985-07-16
CS244445B2 (en) 1986-07-17
PT78934A (de) 1984-08-01
NO842922L (no) 1985-01-21
JPS6038365A (ja) 1985-02-27
EP0131943A2 (de) 1985-01-23
FI842853A0 (fi) 1984-07-16
GB2146019B (en) 1986-11-19
PT78934B (de) 1986-10-23
ES542820A0 (es) 1985-12-16
EP0131943A3 (de) 1985-03-06
ES542819A0 (es) 1986-06-01
ES8601145A1 (es) 1985-10-16
ES8607944A1 (es) 1986-06-01
US4558061A (en) 1985-12-10
CS548584A2 (en) 1985-08-15
DK350284A (da) 1985-01-19
ES534380A0 (es) 1985-10-16

Similar Documents

Publication Publication Date Title
DE2833140C2 (en, 2012)
DE1695556C3 (de) 3-Alkyl-1,2,3,4,4a,9-hexahydropyrazino[1,2-f]morphanthridinderivate
DE2108438C2 (de) 4-(4-Methoxy-benzyl)-imidazolidin-2-one
EP0136658B1 (de) 1-Benzyl-aminoalkyl-pyrrolidinone und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und Arzneimittel
DE2558501C2 (en, 2012)
EP0929516A1 (de) Benzamidinderivate und ihre verwendung als arzneimittel mit ltb4-antagonistischer wirkung
DE2143204C3 (de) N-Fluoralkyl-phenylisopropylamin-Derivate und deren Salze, Verfahren zu deren Herstellung und Arzneimittel auf deren Basis
DE2434911A1 (de) Phenylaethylamin-derivate
DE2461604C2 (en, 2012)
EP0483580A2 (de) 1-(2-Arylethyl)-Pyrrolidine
DD213212A5 (de) Verfahren zur herstellung von 4-methyl-6-phenyl-pyridazin-derivaten
DE2100323C3 (de) Ureido-phenoxy-2-hydroxy-3-alkylaminopropane
DE2818672A1 (de) Alpha-(1-r-3-azetidinyl)-alpha- phenyl-alpha-substituierte-acetamide oder -acetonitrile, verfahren zu ihrer herstellung und verwendung zur behandlung von herzarrhythmien
DE2115926B2 (de) 1-(4-hydroxy-3-dimethylaminosulfamidophenyl)-2-aminoaethanderivate, verfahren zu ihrer herstellung und diese enthaltende mittel
EP0033156A2 (de) 1-Phenyl-2-cyclohexen-1-alkylamin-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
EP0000784B1 (de) 4-Hydroxy-2-Benzimidazolinon-derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE2951247C2 (en, 2012)
DE1620295C3 (de) Isochinolo eckige Klammer auf 2,1-d eckige Klammer zu benzo eckige Klammer auf 1,4 eckige Klammer zu diazepin-6-one
DE2409313C2 (de) 1-[2-Pyrrolyl-(1)-phenoxy]-2-hydroxy-3-aminopropan-derivate, Verfahren zu deren Herstellung und pharmazeutische Präparate
DE2432269A1 (de) Basisch substituierte derivate des 4-hydroxybenzimidazols und verfahren zu ihrer herstellung
DD232695A5 (de) Neue-1-phenylimidazolidin-2-on-derivate, ihre herstellung und verwendung
DE2542791C2 (de) N,N'-Disubstituierte Naphthylacetamidine
EP0003298B1 (de) 4-Hydroxy-2-benzimidazolin-thion-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE2834107A1 (de) Benzylalkoholderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
EP0980351B1 (de) Benzylaminderivate und phenylethylaminderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel